Retracted science and the retraction index.

Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci (2013) 13.37

Misconduct accounts for the majority of retracted scientific publications. Proc Natl Acad Sci U S A (2012) 5.89

On the reproducibility of science: unique identification of research resources in the biomedical literature. PeerJ (2013) 5.11

Causes for the persistence of impact factor mania. MBio (2014) 3.77

Deep impact: unintended consequences of journal rank. Front Hum Neurosci (2013) 2.78

Misconduct policies in high-impact biomedical journals. PLoS One (2012) 2.29

Impacted Science: Impact Is Not Importance. MBio (2015) 2.26

A Framework for Improving the Quality of Research in the Biological Sciences. MBio (2016) 2.24

A comprehensive survey of retracted articles from the scholarly literature. PLoS One (2012) 1.87

Reforming science: methodological and cultural reforms. Infect Immun (2011) 1.85

Specialized science. Infect Immun (2014) 1.61

Sources of error in the retracted scientific literature. FASEB J (2014) 1.60

Financial costs and personal consequences of research misconduct resulting in retracted publications. Elife (2014) 1.59

Why growing retractions are (mostly) a good sign. PLoS Med (2013) 1.57

Quantifying reproducibility in computational biology: the case of the tuberculosis drugome. PLoS One (2013) 1.56

Visibility of retractions: a cross-sectional one-year study. BMC Res Notes (2013) 1.40

Frequency of discrepancies in retracted clinical trial reports versus unretracted reports: blinded case-control study. BMJ (2015) 1.39

Retraction policies of top scientific journals ranked by impact factor. J Med Libr Assoc (2015) 1.31

Journal publishing: the changing landscape. Indian J Med Res (2013) 1.19

Misconduct Policies, Academic Culture and Career Stage, Not Gender or Pressures to Publish, Affect Scientific Integrity. PLoS One (2015) 1.12

Fate of articles that warranted retraction due to ethical concerns: a descriptive cross-sectional study. PLoS One (2014) 1.00

A comprehensive analysis of articles retracted between 2004 and 2013 from biomedical literature - a call for reforms. J Tradit Complement Med (2014) 0.97

The natural selection of bad science. R Soc Open Sci (2016) 0.93

The Prevalence of Inappropriate Image Duplication in Biomedical Research Publications. MBio (2016) 0.91

Significance chasing in research practice: causes, consequences and possible solutions. Addiction (2014) 0.87

What studies of retractions tell us. J Microbiol Biol Educ (2014) 0.86

What is open peer review? A systematic review. F1000Res (2017) 0.83

The reproducibility of biomedical research: Sleepers awake! Biomol Detect Quantif (2015) 0.79

THE ART OF SMART SCIENCE: WEAVING THEORY AND RISKY STUDY DESIGN INTO PSYCHOPATHOLOGY RESEARCH AND RDOC. Psychol Inq (2015) 0.78

Retractions of scientific publications: responsibility and accountability. Biochem Med (Zagreb) (2014) 0.78

Authentication: A Standard Problem or a Problem of Standards? PLoS Biol (2016) 0.77

Improving the reliability of peer-reviewed publications: We are all in it together. Biomol Detect Quantif (2015) 0.76

F1000Research: Tics welcomes you to 21st century biomedical publishing. F1000Res (2014) 0.76

Redrawing the frontiers in the age of post-publication review. Front Genet (2015) 0.75

Paper-trail index: Can a metric that captures a paper's history of submission and rejection give insight into its value and encourage good authorship practices? EMBO Rep (2015) 0.75

Likelihood of false-positive results in high-impact journals publishing groundbreaking research. Infect Immun (2012) 0.75

Magazine or journal--what is the difference? The role of the monitoring editor. Mol Biol Cell (2013) 0.75

Publish or Perish mantra in the medical field: A systematic review of the reasons, consequences and remedies. Pak J Med Sci (2017) 0.75

Ethics in Science. Indian J Microbiol (2015) 0.75

Internet publicity of data problems in the bioscience literature correlates with enhanced corrective action. PeerJ (2014) 0.75

47 Years of IAI- A Glance in the Mirror and the Road Ahead. Infect Immun (2017) 0.75

Novel or reproducible: That is the question. Glycobiology (2016) 0.75

Retractions in orthopaedic research: A systematic review. Bone Joint Res (2016) 0.75

Irreproducibility of published bioscience research: Diagnosis, pathogenesis and therapy. Mol Metab (2016) 0.75

Ethical publishing in intensive care medicine: A narrative review. World J Crit Care Med (2016) 0.75

The visibility of scientific misconduct: A review of the literature on retracted journal articles. Curr Sociol (2016) 0.75

Retracted Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet (1998) 36.93

Why the impact factor of journals should not be used for evaluating research. BMJ (1997) 28.43

How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS One (2009) 11.72

A tale of two citations. Nature (2008) 9.19

Retracted Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science (2004) 7.37

Retracted A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med (2006) 6.69

What's in a picture? The temptation of image manipulation. J Cell Biol (2004) 6.04

Retracted Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science (2005) 5.21

Research misconduct, retraction, and cleansing the medical literature: lessons from the Poehlman case. Ann Intern Med (2006) 4.76

Impact factor as a misleading tool in evaluation of medical journals. Lancet (1995) 4.31

Retractions in the scientific literature: is the incidence of research fraud increasing? J Med Ethics (2010) 3.69

Scientific integrity. Responding to possible plagiarism. Science (2009) 3.26

Retractions in the research literature: misconduct or mistakes? Med J Aust (2006) 3.17

Phenomena of retraction: reasons for retraction and citations to the publications. JAMA (1998) 3.13

Special report: taking on the cheats. Nature (2005) 3.07

Retracted Multiple sclerosis and Epstein-Barr virus. JAMA (2003) 2.68

Rules of the game of scientific writing: fair play and plagiarism. Lancet (2007) 2.52

Why and how do journals retract articles? An analysis of Medline retractions 1988-2008. J Med Ethics (2011) 2.46

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA (2005) 2.23

Persistence of contradicted claims in the literature. JAMA (2007) 1.90

Retracted The large-conductance Ca2+-activated K+ channel is essential for innate immunity. Nature (2004) 1.85

Impact factor: good reasons for concern. Epidemiology (2008) 1.71

Lost in translation--basic science in the era of translational research. Infect Immun (2009) 1.70

The most influential journals: Impact Factor and Eigenfactor. Proc Natl Acad Sci U S A (2009) 1.66

Chinese journal finds 31% of submissions plagiarized. Nature (2010) 1.66

Descriptive science. Infect Immun (2008) 1.65

Retracted Directional gene movement from human-pathogenic to commensal-like streptococci. Infect Immun (2001) 1.61

Important science--it's all about the SPIN. Infect Immun (2009) 1.59

Retracted Localization of BmpA on the exposed outer membrane of Borrelia burgdorferi by monospecific anti-recombinant BmpA rabbit antibodies. Infect Immun (2004) 1.56

An integrated approach to evaluate faculty members' research performance. Acad Med (2009) 1.56

Retraction policies of high-impact biomedical journals. J Med Libr Assoc (2004) 1.54

How long does it take for the scientific literature to purge itself of fraudulent material?: the Breuning case revisited. Curr Med Res Opin (2010) 1.51

Investigating the previous studies of a fraudulent author. BMJ (2005) 1.47

Plagiarism? No, we're just borrowing better English. Nature (2007) 1.43

Plagiarism: understanding and management. J Perioper Pract (2007) 1.42

Retracted Differences in levels of secreted locus of enterocyte effacement proteins between human disease-associated and bovine Escherichia coli O157. Infect Immun (2001) 1.37

Empirical developments in retraction. J Med Ethics (2008) 1.37

Mechanistic science. Infect Immun (2009) 1.29

Falsified papers in high-impact journals were slow to retract and indistinguishable from nonfraudulent papers. J Clin Epidemiol (2008) 1.26

Scientific misconduct. Cleaning up the paper trail. Science (2006) 1.26

The scientific community's response to evidence of fraudulent publication. The Robert Slutsky case. JAMA (1994) 1.25

Retractions in the medical literature: how many patients are put at risk by flawed research? J Med Ethics (2011) 1.15

Reproducible science. Infect Immun (2010) 1.14

Beware the tyranny of impact factors. J Bone Joint Surg Br (2008) 1.13

Self-plagiarism and dual and redundant publications: what is the problem? Commentary on 'Seven ways to plagiarize: handling real allegations of research misconduct'. Sci Eng Ethics (2002) 1.09

Retracted An organic solid state injection laser. Science (2000) 1.08

Sialic acids acquired by Pseudomonas aeruginosa are involved in reduced complement deposition and siglec mediated host-cell recognition. FEBS Lett (2009) 1.08

Retracted Induction of monocyte chemoattractant protein 1 by Helicobacter pylori involves NF-kappaB. Infect Immun (2001) 1.04

Retracted Activation of intercellular adhesion molecule 1 expression by Helicobacter pylori is regulated by NF-kappaB in gastric epithelial cancer cells. Infect Immun (2000) 1.04

The effectiveness of the practice of correction and republication in the biomedical literature. J Med Libr Assoc (2010) 1.01

Retracted A light-emitting field-effect transistor. Science (2000) 1.01

Authorship and publication practices: evaluation of the effect of responsible conduct of research instruction to postdoctoral trainees. Account Res (2008) 1.01

Misinformation in the medical literature: what role do error and fraud play? J Med Ethics (2011) 0.99

Reductionistic and holistic science. Infect Immun (2011) 0.99

Retracted Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells. Infect Immun (2002) 0.96

Retracted High-frequency invasion of epithelial cells by Streptococcus pyogenes can be activated by fibrinogen and peptides containing the sequence RGD. Infect Immun (1997) 0.96

Retracted Inhibition of growth of Mycobacterium avium in murine and human mononuclear phagocytes by migration inhibitory factor. Infect Immun (1993) 0.95

Retracted Essential role of transcription factor nuclear factor-kappaB in regulation of interleukin-8 gene expression by nitrite reductase from Pseudomonas aeruginosa in respiratory epithelial cells. Infect Immun (1999) 0.93

Retracted Field-effect modulation of the conductance of single molecules. Science (2001) 0.93

Dubious data remain in print two years after misconduct inquiry. Nature (2002) 0.93

An unwelcome discovery. Walter DeNino was a young lab technician who analyzed data for his mentor, Eric Poehlman. What he found was that Poehlman was not the scientist he appeared to be. N Y Times Mag (2006) 0.92

It's difficult to publish contradictory findings. Nature (2006) 0.91

Retracted Josephson junctions with tunable weak links. Science (2001) 0.91

Retracted Ambipolar pentacene field-effect transistors and inverters. Science (2000) 0.90

Retracted Helicobacter pylori induces CCL20 expression. Infect Immun (2007) 0.90

Scientific misconduct and correcting the scientific literature. Acad Med (1999) 0.90

Retracted Helicobacter pylori induces RANTES through activation of NF-kappa B. Infect Immun (2003) 0.87

Retracted R plasmid in Escherichia coli O103 coding for colonization of the rabbit intestinal tract. Infect Immun (1991) 0.87

Retracted Molecular cloning, characterization, and expression in Escherichia coli of iron superoxide dismutase cDNA from Leishmania donovani chagasi. Infect Immun (1994) 0.86

Retracted Helicobacter pylori-induced interleukin-12 p40 expression. Infect Immun (2009) 0.85

A rhetorical analysis of apologies for scientific misconduct: do they really mean it? Sci Eng Ethics (2009) 0.85

Retractions: guidance from the Committee on Publication Ethics (COPE). Obes Rev (2010) 0.85

Duplication and plagiarism increasing among students. Nature (2008) 0.83

Mistakes and misconduct in the research literature: retractions just the tip of the iceberg. Med J Aust (2007) 0.82

Retraction controversy. Cell (2005) 0.79

Citation of retracted articles: a call for vigilance. Ann Thorac Surg (2009) 0.79

Letter of rebuttal and apology to editor on the retraction of "Velocity of polymer translocation through a pore". Biochem Biophys Res Commun (2009) 0.79

Retracted Psychiatric side effects during methysergide treatment. J Neurol Neurosurg Psychiatry (2005) 0.79

Retracted High-temperature superconductivity in lattice-expanded C60. Science (2001) 0.79

The Impact Factor: time for change. Aust N Z J Psychiatry (2001) 0.79

Problems with anti-plagiarism database. Nature (2009) 0.78

Plagiarism. Trans R Soc Trop Med Hyg (2009) 0.78

RETRACTED: Sialic acids, important constituents and selective recognition factors of Pseudomonas aeruginosa, an opportunistic pathogen. Infect Immun (2009) 0.78

Retracted Fractional quantum hall effect in organic molecular semiconductors. Science (2000) 0.78

Retracted A superconducting field-effect switch. Science (2000) 0.78

Apathy rewards misconduct--and everybody suffers. Nature (2000) 0.78

Plagiarism. Trans R Soc Trop Med Hyg (2010) 0.78

Correcting the literature--retraction and republication. JAMA (2005) 0.78

Misconduct accounts for the majority of retracted scientific publications. Proc Natl Acad Sci U S A (2012) 5.89

Selective silencing of foreign DNA with low GC content by the H-NS protein in Salmonella. Science (2006) 4.60

Causes for the persistence of impact factor mania. MBio (2014) 3.77

Why has the number of scientific retractions increased? PLoS One (2013) 3.59

Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis (2013) 3.56

The contribution of melanin to microbial pathogenesis. Cell Microbiol (2003) 3.12

Cryptococcosis. Infect Dis Clin North Am (2002) 3.01

Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr Biol (2006) 2.92

Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc Natl Acad Sci U S A (2002) 2.68

Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell (2006) 2.55

Public health and biosecurity. Adaptations of avian flu virus are a cause for concern. Science (2012) 2.52

Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot Cell (2007) 2.42

Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol (2010) 2.32

NIH peer review reform--change we need, or lipstick on a pig? Infect Immun (2009) 2.21

Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob Agents Chemother (2006) 2.12

A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity. Science (2008) 2.10

The alternative sigma factor sigmaE controls antioxidant defences required for Salmonella virulence and stationary-phase survival. Mol Microbiol (2002) 2.08

The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction. J Biol Chem (2005) 2.07

Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe (2013) 2.06

Fungal cell gigantism during mammalian infection. PLoS Pathog (2010) 2.04

Silencing of xenogeneic DNA by H-NS-facilitation of lateral gene transfer in bacteria by a defense system that recognizes foreign DNA. Genes Dev (2007) 2.03

Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol Microbiol (2003) 2.01

High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol (2012) 2.00

Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages. Infect Immun (2003) 2.00

The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol (2009) 1.97

Characterization of six lipoproteins in the sigmaE regulon. J Bacteriol (2005) 1.91

PoxA, yjeK, and elongation factor P coordinately modulate virulence and drug resistance in Salmonella enterica. Mol Cell (2010) 1.89

Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2). Infect Immun (2003) 1.89

The nitrosative stress response of Staphylococcus aureus is required for resistance to innate immunity. Mol Microbiol (2006) 1.86

Multiple targets of nitric oxide in the tricarboxylic acid cycle of Salmonella enterica serovar typhimurium. Cell Host Microbe (2011) 1.86

Reforming science: methodological and cultural reforms. Infect Immun (2011) 1.85

The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect (2003) 1.84

CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity (2002) 1.83

More is not necessarily better: prozone-like effects in passive immunization with IgG. J Immunol (2003) 1.81

Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ. Mol Microbiol (2005) 1.80

Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Invest (2011) 1.80

An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov (2010) 1.78

Nontoxic radioactive Listeria(at) is a highly effective therapy against metastatic pancreatic cancer. Proc Natl Acad Sci U S A (2013) 1.76

Vesicular transport in Histoplasma capsulatum: an effective mechanism for trans-cell wall transfer of proteins and lipids in ascomycetes. Cell Microbiol (2008) 1.73

Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol Microbiol (2007) 1.73

Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proc Natl Acad Sci U S A (2003) 1.71

Ionizing radiation changes the electronic properties of melanin and enhances the growth of melanized fungi. PLoS One (2007) 1.70

What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J Clin Microbiol (2010) 1.70

Lost in translation--basic science in the era of translational research. Infect Immun (2009) 1.70

Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol (2004) 1.67

The immunoglobulin heavy chain constant region affects kinetic and thermodynamic parameters of antibody variable region interactions with antigen. J Biol Chem (2007) 1.67

Descriptive science. Infect Immun (2008) 1.65

Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot Cell (2004) 1.64

The presence of female conveners correlates with a higher proportion of female speakers at scientific symposia. MBio (2014) 1.63

Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryot Cell (2007) 1.63

Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc Natl Acad Sci U S A (2010) 1.62

The response regulator SsrB activates expression of diverse Salmonella pathogenicity island 2 promoters and counters silencing by the nucleoid-associated protein H-NS. Mol Microbiol (2007) 1.61

Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis. Antimicrob Agents Chemother (2005) 1.61

Specialized science. Infect Immun (2014) 1.61

An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia. J Immunol (2005) 1.61

Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest (2003) 1.60

Important science--it's all about the SPIN. Infect Immun (2009) 1.59

Maintenance of nitric oxide and redox homeostasis by the salmonella flavohemoglobin hmp. J Biol Chem (2006) 1.58

A requirement for FcγR in antibody-mediated bacterial toxin neutralization. J Exp Med (2010) 1.58

Ionizing radiation: how fungi cope, adapt, and exploit with the help of melanin. Curr Opin Microbiol (2008) 1.58

Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. Antimicrob Agents Chemother (2002) 1.57

Global warming will bring new fungal diseases for mammals. MBio (2010) 1.56

Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog (2007) 1.55

Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials. Am J Trop Med Hyg (2012) 1.55

Policy: Adaptations of avian flu virus are a cause for concern. Nature (2012) 1.54

Inhibition of bacterial DNA replication by zinc mobilization during nitrosative stress. Proc Natl Acad Sci U S A (2003) 1.53

Experimental modulation of capsule size in Cryptococcus neoformans. Biol Proced Online (2004) 1.52

Vertebrate endothermy restricts most fungi as potential pathogens. J Infect Dis (2009) 1.51

Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. BMC Immunol (2007) 1.51

Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog (2010) 1.50

Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell Microbiol (2008) 1.50

Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes. J Nucl Med (2004) 1.47

Interaction of radiolabeled antibodies with fungal cells and components of the immune system in vitro and during radioimmunotherapy for experimental fungal infection. J Infect Dis (2006) 1.47

Monoclonal antibody-based therapies for microbial diseases. Vaccine (2009) 1.47

The Salmonella enterica serovar typhimurium divalent cation transport systems MntH and SitABCD are essential for virulence in an Nramp1G169 murine typhoid model. Infect Immun (2004) 1.46

Sec6-dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans. Mol Microbiol (2008) 1.46

Synthesis and assembly of fungal melanin. Appl Microbiol Biotechnol (2011) 1.45

The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Eur J Immunol (2003) 1.45

Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot Cell (2007) 1.45

Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum. Infect Immun (2003) 1.44

The ferritin-like Dps protein is required for Salmonella enterica serovar Typhimurium oxidative stress resistance and virulence. Infect Immun (2004) 1.44

The effect of L-DOPA on Cryptococcus neoformans growth and gene expression. Virulence (2011) 1.42

Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother (2006) 1.42

Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect Immun (2005) 1.42

Comparison of the PhoPQ regulon in Escherichia coli and Salmonella typhimurium. J Mol Evol (2005) 1.41

Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection. Proc Natl Acad Sci U S A (2010) 1.41

Microstructure of cell wall-associated melanin in the human pathogenic fungus Cryptococcus neoformans. Biochemistry (2005) 1.40

Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood (2009) 1.40

Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions. Infect Immun (2010) 1.40

Experimental murine cryptococcal infection results in contamination of bedding with Cryptococcus neoformans. Contemp Top Lab Anim Sci (2003) 1.40

The global regulator ArcA controls resistance to reactive nitrogen and oxygen intermediates in Salmonella enterica serovar Enteritidis. Infect Immun (2002) 1.39

Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot Cell (2007) 1.39

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. PLoS Med (2006) 1.38

Clinical isolates of Staphylococcus intermedius masquerading as methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2004) 1.38